Skip to content

AcrySof Toric IQ A-code Post-Market Clinical Study

AcrySof Toric IQ A-code Post-Market Clinical Study - AcrySof Toric IQ Post-Market Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030848
Enrollment
120
Registered
2018-01-19
Start date
2018-01-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract

Interventions

AcrySof IQ Toric A-code IOL Intended to provide visual acuity, including astigmatism correction, over the lifetime of the cataract patient

Sponsors

Alcon Japan Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Diagnosis of cataracts with planned cataract removal by phacoemulsification -Calculated lens power within the available range -Able to sign informed consent and complete all study visits -Other protocol-defined inclusion criteria may apply.

Exclusion criteria

Exclusion criteria: -Eye conditions as specified in the protocol -Uncontrolled glaucoma -Pregnancy, current or planned -Other protocol-defined exclusion criteria may apply.

Design outcomes

Primary

MeasureTime frame
1. Percentage of patients with absolute value of IOL rotation of less than 10 degrees at Visit 4 from Visit 00 IOL rotation is defined as the IOL axis difference between study visits. A photograph of the eye will be taken, and IOL rotation will be calculated as the angle between the toric mark on the IOL at Visit 4 and the reference point from Visit 00 (minimum 0 degrees, maximum 180 degrees). A lower value indicates greater IOL stability. [Time Frame: Visit 00 (Day 1 operative), Visit 4 (Day 120-180 postoperative)] 2. Percentage of patients with absolute value of IOL rotation of less than 20 degrees at Visit 4 from Visit 00 [Time Frame: Visit 00 (Day 1 operative), Visit 4 (Day 120-180 postoperative)] 3. Percentage of patients with absolute value of IOL rotation of less than 30 degrees at Visit 4 from Visit 00 [Time Frame: Visit 00 (Day 1 operative), Visit 4 (Day 120-180 postoperative)]

Countries

Japan

Contacts

Public ContactMayu Saito

Alcon Japan Ltd. Clinical Development

clinicalstudy.japan@alcon.com03-6899-5061

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026